88 related articles for article (PubMed ID: 7693579)
21. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M
Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796
[TBL] [Abstract][Full Text] [Related]
22. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
23. CD7-positive acute myeloid leukemia: further evidence of cellular immaturity.
Kondo S; Okamura S; Harada N; Ikematsu W; Kawasaki C; Fukuda T; Kubota A; Shimoda K; Harada M; Shibuya T
J Cancer Res Clin Oncol; 1992; 118(5):386-8. PubMed ID: 1374757
[TBL] [Abstract][Full Text] [Related]
24. Antibodies TC-12 ("unique") and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia.
Gramatzki M; Ludwig WD; Burger R; Moos P; Rohwer P; Grünert C; Sendler A; Kalden JR; Andreesen R; Henschke F; Moldenhauer G
Exp Hematol; 1998 Dec; 26(13):1209-14. PubMed ID: 9845376
[TBL] [Abstract][Full Text] [Related]
25. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
26. CD79 alpha expression in acute myeloid leukemia. High frequency of expression in acute promyelocytic leukemia.
Arber DA; Jenkins KA; Slovak ML
Am J Pathol; 1996 Oct; 149(4):1105-10. PubMed ID: 8863659
[TBL] [Abstract][Full Text] [Related]
27. A case of mixed lineage acute non-lymphocytic leukemia with t(5;12)(p13;p13).
Shimizu S; Tsunematsu Y; Fujimoto J; Mizutani S; Kaneko Y
Jpn J Clin Oncol; 1991 Aug; 21(4):314-7. PubMed ID: 1942561
[TBL] [Abstract][Full Text] [Related]
28. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
29. Clinical and biological relevance of flow cytometric determination of P-glycoprotein expression in acute non-lymphocytic leukemia.
Li J; Xia X; Hua D; Wang W; Chen Z; Ruan C
Chin Med J (Engl); 1997 Dec; 110(12):919-22. PubMed ID: 9772402
[TBL] [Abstract][Full Text] [Related]
30. [Classification of ninety-eight adult cases of acute leukemia according to morphology, immunology and cytogenetics].
Li J; Xue Y; Xia X
Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):150-3. PubMed ID: 9206053
[TBL] [Abstract][Full Text] [Related]
31. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias.
Lai R; Juco J; Lee SF; Nahirniak S; Etches WS
Am J Clin Pathol; 2000 Jun; 113(6):823-30. PubMed ID: 10874883
[TBL] [Abstract][Full Text] [Related]
33. [The diagnostic significance of blast immunophenotype assay in patients with acute leukemia].
Piatoska-Jakubas B; Pituch-Noworolska A; Skotnicki AB; Balana-Nowak A
Acta Haematol Pol; 1996; 27(1):33-41. PubMed ID: 8629441
[TBL] [Abstract][Full Text] [Related]
34. Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital.
Ghosh S; Shinde SC; Kumaran GS; Sapre RS; Dhond SR; Badrinath Y; Ansari R; Kumar A; Mahadik S; Chougule AB; Nair CN
Indian J Cancer; 2003; 40(2):71-6. PubMed ID: 14716122
[TBL] [Abstract][Full Text] [Related]
35. [Immunophenotypes and FAB classification].
Kageyama S; Nakase K; Kita K; Nasu K; Dohy H; Shirakawa S
Rinsho Ketsueki; 1992 May; 33(5):604-7. PubMed ID: 1378516
[No Abstract] [Full Text] [Related]
36. Aberrant expression of T-cell markers in acute myeloid leukemia.
Lewis RE; Cruse JM; Sanders CM; Webb RN; Suggs JL
Exp Mol Pathol; 2007 Dec; 83(3):462-3. PubMed ID: 17927977
[TBL] [Abstract][Full Text] [Related]
37. [Analysis of cytoplasmic antigens in acute leukemia by flow cytometry].
Kawai S; Zha Z; Yamamoto Y; Nakadate H; Kawakami K; Kikuta A; Utsumi J; Nishikawa K; Mimaya J; Miyake M
Rinsho Ketsueki; 1993 Jan; 34(1):13-20. PubMed ID: 8450602
[TBL] [Abstract][Full Text] [Related]
38. CD7+ acute non-lymphocytic leukemia: evidence for an early multipotential progenitor.
Zutter MM; Martin PJ; Hanke D; Kidd PG
Leuk Res; 1990; 14(1):23-6. PubMed ID: 1689436
[TBL] [Abstract][Full Text] [Related]
39. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia.
Miwa H; Kita K; Nishii K; Morita N; Takakura N; Ohishi K; Mahmud N; Kageyama S; Fukumoto M; Shirakawa S
Blood; 1993 Dec; 82(11):3445-51. PubMed ID: 7694687
[TBL] [Abstract][Full Text] [Related]
40. Bcl-2 expression in acute myelogenous leukemia: the relation to myeloid antigen expression and response to therapy in Iranian patients.
Daneshbod Y; Amirghofran Z; Tabei SZ
Neoplasma; 2005; 52(2):109-14. PubMed ID: 15800708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
